MBZUAI researchers are working on digital twin technology that can replicate human beings in detail, with real-time data flow between the physical and virtual. This project aims to extend digital twins from objects to organic entities like humans, plants and animals. The technology mines data from cameras, sensors, wearables, and other sources to predict health issues before they arise. Why it matters: This research has the potential to transform healthcare by enabling the prediction and prevention of health issues.
Eran Segal from Weizmann Institute of Science presented The Human Phenotype Project, a large-scale prospective cohort with over 10,000 participants. The project aims to identify novel molecular markers and develop prediction models for disease onset using deep profiling. The profiling includes medical history, lifestyle, blood tests, and molecular profiling of the transcriptome, genetics, microbiome, metabolome and immune system. Why it matters: Such projects demonstrate the growing focus on personalized medicine in the region, utilizing advanced AI and machine learning techniques for disease prevention and treatment.
Professor Eran Segal presented The Human Phenotype Project, a longitudinal cohort study with over 10,000 participants. The project aims to identify molecular markers and develop prediction models for disease using deep profiling techniques including medical history, lifestyle, blood tests, and microbiome analysis. The study provides insights into drivers of obesity, diabetes, and heart disease, identifying novel markers at the microbiome, metabolite, and immune system level. Why it matters: Such large-scale phenotyping initiatives could inform personalized medicine approaches relevant to the Middle East's specific health challenges.
Researchers at MBZUAI developed a method to measure vital signs using webcams by analyzing color intensity changes in facial blood flow. They built a digital twin system that uses machine learning to combine heart rate, respiratory rate, and blood oxygen level measures. The system displays real-time vital sign information, enabling remote patient triage. Why it matters: This research contributes to the advancement of telemedicine, potentially improving healthcare access in underserved regions and aligning with UN Sustainable Development Goal #3.
Pietro Liò from the University of Cambridge will discuss geometric deep learning techniques for building a digital patient twin using graph and hypergraph representation learning. The talk will focus on integrating Computational Biology and Deep Learning, considering physiological, clinical, and molecular variables. He will also cover explainable methodologies for clinicians and protein design using diffusion models. Why it matters: This highlights the growing interest in applying advanced AI techniques like geometric deep learning and diffusion models to healthcare challenges in the region, particularly for personalized medicine.
Eduardo da Veiga Beltrame, bioinformatics lead at ImYoo (a Caltech spinout), presented on scalable methods for single-cell omics data analysis, including kallisto|bustools and scvi-tools. He highlighted their use in ImYoo's decentralized longitudinal study on Inflammatory Bowel Disease (IBD), where patients self-collect capillary blood samples. Beltrame also discussed his research on STEM education programs in Brazil as a visiting scholar at UC Berkeley. Why it matters: This highlights the growing trend of decentralized clinical studies leveraging advanced single-cell technologies for precision medicine, showcasing the potential of remote data collection and analysis in understanding complex diseases.
The Human Phenotype Project (HPP), led by researchers from Mohamed bin Zayed University of Artificial Intelligence (MBZUAI), published findings in Nature Medicine detailing an understanding of the health-disease continuum. The HPP involves deep and longitudinal profiling of approximately 28,000 participants, collecting diverse data including medical history, lifestyle, blood tests, and molecular profiling. The project aims to create AI-based predictive models for disease onset and progression, and digital twins to simulate interventions. Why it matters: This research can transform precision medicine and preventative care in the UAE by creating personalized digital twins that can simulate interventions and predict health trajectories.
Shahar Harel, Head of AI at Quris, presented a BIO-AI approach to drug safety assessment using a 'patient-on-a-chip' platform. This platform simulates the human body and generates high-frequency microscopy and biochemical data on drug interactions, considering patient genomics and ethnicity. The data is used to train multimodal deep learning models to predict drug safety and provide patient-specific recommendations. Why it matters: This approach offers a potential alternative to animal models, promising faster and more personalized drug development while reducing safety concerns.